Challenges in treating pediatric asthma in developing countries

Pediatric Drugs

Volumn 14, Issue 6, 2012, Pages 353-359

  Zar, Heather J ^a   Levin, Michael E ^a  

^a RED CROSS WAR MEMORIAL CHILDREN S HOSPITAL   (South Africa)

Author keywords

Asthma; Children

Indexed keywords

BECLOMETASONE; BRONCHODILATING AGENT; CORTICOSTEROID; SALBUTAMOL;

AIR POLLUTION; ARTICLE; ASTHMA; BRONCHOSCOPY; CHILDHOOD DISEASE; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; DIAGNOSTIC ACCURACY; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; EMERGENCY WARD; ENVIRONMENTAL FACTOR; FOLLOW UP; FORCED EXPIRATORY FLOW; HEALTH CARE PERSONNEL; HEALTH SERVICE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LANGUAGE; LOW DRUG DOSE; MEDICAL EDUCATION; MORBIDITY; MORTALITY; PATIENT EDUCATION; PEDIATRICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; SMOKING; SOCIAL ASPECT; SOCIOECONOMICS; WHEEZING;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ASTHMA; BRONCHODILATOR AGENTS; COMMUNICATION BARRIERS; COST-BENEFIT ANALYSIS; COUNTERFEIT DRUGS; DEVELOPING COUNTRIES; DRUGS, ESSENTIAL; HUMANS; INFANT; METERED DOSE INHALERS; PATIENT EDUCATION AS TOPIC; SOCIOECONOMIC FACTORS; TERMINOLOGY AS TOPIC;

EID: 84867345115     PISSN: 11745878     EISSN: 11792019     Source Type: Journal    
DOI: 10.2165/11597420-000000000-00000     Document Type: Article

References (61)

1. Asher MI, Montefort S, Bjorksten B, et al., and the ISAAC Phase Three Study Group. Worldwide trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lancet 2006; 368: 733-7
2. Pearce N, Ait-Khaled N, Beasley R, et al., and the ISAAC Phase Three Study Group. Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2007; 62: 757-65 (Pubitemid 47435029)
3. Ait-Khaled N, Odhiambo J, Pearce N, et al. Prevalence of symptoms of asthma, rhinitis and eczema in 13- to 14-year-old children in Africa: the International Study of Asthma and Allergies in Childhood Phase III. Allergy 2007 Mar; 62 (3): 247-58
4. Lai CK, Beasley R, Crane J, et al., International Study of Asthma and Allergies in Childhood Phase Three Study Group. Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2009; 64: 476-83
5. Crane J, Mallol J, Beasley R, et al. Agreement between written and video questions for comparing asthma symptoms in ISAAC. International Study of Asthma and Allergies in Childhood Phase I Study Group. Eur Respir J 2003 Mar; 21 (3): 455-61 (Pubitemid 36336204)
6. Masoli M, Fabian D, Holt S, et al., Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004; 59 (5): 469-78 (Pubitemid 38580764)
7. World Health Organisation. WHO indicator and measurement registry [online]. Available from URL: http://apps.who.int/gho/indicatorregistry [Accessed 2012 Aug 1]
8. Lalloo UG, Walters RD, Adachi M, et al. Asthma programs in diverse regions of the world: challenges, successes and lessons learnt. Int J Tuber Lung Dis 2011; 15 (12): 1574-87
9. Tan WC. Asthma management in the developing world: achievements and challenges. Expert Rev Respir Med 2008; 2 (3): 323-8 (Pubitemid 351959391)
10. Pedersen SE, Hurd SS, Lemanske Jr RF, et al. Global strategy for the diagnosis and management of asthma in children 5 years and younger. Pediatr Pulmonol 2011; 46: 1-17
11. Castro-Rodriguez JA, Holberg CJ, Wright AL, et al. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med 2000; 162 (4 Pt 1): 1403-6
12. Weinmayr G, Weiland SK, Björkstén B, et al. Atopic sensitization and the international variation of asthma symptom prevalence in children. Am J Respir Crit Care Med 2007; 176 (6): 565-74 (Pubitemid 47403274)
13. Padhi BK, Padhy PK. Domestic fuels, indoor air pollution, and children's health. Ann N Y Acad Sci 2008; 1140: 209-17
14. Stern DA, Morgan WJ, Halonen M, et al. Wheezing and bronchial hyperresponsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: a longitudinal birth-cohort study. Lancet 2008; 372 (9643): 1058-64
15. Stocks J, Dezateux C. The effect of parental smoking on lung function and development during infancy. Respirology 2003; 8 (3): 266-85 (Pubitemid 37163112)
16. Dezateux C, Stocks J, Wade AM, et al. Airway function at one year: association with premorbid airway function, wheezing, and maternal smoking. Thorax 2001; 56 (9): 680-6 (Pubitemid 32831694)
17. Miller RL, Ho SM. Environmental epigenetics and asthma: current concepts and call for studies. Am J Respir Crit Care Med 2008; 177 (6): 567-73 (Pubitemid 351442162)
18. Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2011 [online]. Available from URL: http://www.ginasthma.org [Accessed 2012 Aug 23]
19. Brand PL, Baraldi E, BisgaardH, et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J 2008; 32 (4): 1096-110
20. Cates CJ, Crilly JA, Rowe BH. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev 2006 Apr 19; (2): CD000052
21. Zar HJ, Weinberg EG. Spacer devices for the developing world. ACI International 2002; 14 (1): 13-6 (Pubitemid 34157188)
22. WHO model list of essential medicines, 15th list, March 2007. Geneva: World Health Organization, 2007 [online]. Available from URL: http://www.who.int/medicines/publications/essentialmedicines/en/index.html [Accessed 2012 Aug 24]
23. Zar HJ, Brown G, Donson H, et al. Home-made spacers for bronchodilator therapy in children with acute asthma: a randomised trial. Lancet 1999; 354: 979-82 (Pubitemid 29438403)
24. Rodriguez C, Sossa M, Lozano JM. Commercial versus home-made spacers in delivering bronchodilator therapy for acute therapy in children. Cochrane Database Syst Rev 2008; (2): CD005536
25. Zar H, Streun S, Levin M, et al. Randomised controlled trial of the efficacy of a metered dose inhaler with bottle spacer for bronchodilator therapy in acute lower airway obstruction. Arch Dis Child 2007; 92: 142-6
26. Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006; 354 (19): 1985-97
27. Lemanske Jr RF, Mauger DT, Sorkness CA, et al. Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. N Engl J Med 2010; 362 (11): 975-85
28. Ellis EF. Theophylline toxicity. J Allergy Clin Immunol 1985; 76 (2 Pt 2): 297-301 (Pubitemid 16247821)
29. Mendis S, Fukino K, Cameron A, et al. The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. Bull World Health Organ 2007; 85 (4): 279-88 (Pubitemid 46556727)
30. Kotwani A. Availability, price and affordability of asthma medicines in five Indian states. Int J Tuberc Lung Dis 2009; 13 (5): 574-9
31. Robertson J, Forte G, Trapsida JM, et al. What essential medicines for children are on the shelf? Bull World Health Organ 2009; 87 (3): 231-7
32. Mackey TK, Liang BA. The global counterfeit drug trade: patient safety and public health risks. J Pharm Sci 2011; 100 (11): 4571-9
33. USAID. Promoting the quality of medicines in developing countries [online]. Available from URL: http://www.usp.org/worldwide/ [Accessed 2011 Oct 25]
34. Franco R, Santos AC, do Nascimento HF, et al. Cost-effectiveness analysis of a state funded programme for control of severe asthma. BMC Public Health 2007; 7: 82
35. Ponte E, Franco RA, Souza-Machado A, et al. Impact that a program to control severe asthma has on the use of Unified Health System resources in Brazil. J Bras Pneumol 2007; 33 (1): 15-9
36. Neffen H, Baena-Cagnani C, Passalacqua G, et al. Asthma mortality, inhaled steroids, and changing asthma therapy in Argentina (1990-1999). Respir Med 2006; 100: 1431-5 (Pubitemid 43942321)
37. Kupczyk M, Haahtela T, Cruz AA, et al. Reduction of asthma burden is possible through National Asthma Plans. Allergy 2010; 65 (4): 415-9
38. Flores G, Snowden-Bridon C, Torres S, et al. Urban minority children with asthma: substantial morbidity, compromised quality and access to specialists, and the importance of poverty and specialty care. J Asthma 2009; 46 (4): 392-8
39. Kim H, Kieckhefer GM, Greek AA, et al. Health care utilization by children with asthma. Prev Chronic Dis 2009; 6 (1): A12
40. Zar HJ, Stickells D, Toerien A, et al. Changes in fatal and near fatal asthma in an urban area of South Africa from 1980-1997. Eur Respir J 2001; 18: 33-7 (Pubitemid 32717428)
41. Cane RS, McKenzie SA. Parents' interpretations of children's respiratory symptoms on video. Arch Dis Child 2001; 84: 31-4 (Pubitemid 32060133)
42. Michel G, Silverman M, Strippoli MP, et al. Parental understanding of wheeze and its impact on asthma prevalence estimates. Eur Respir J 2006; 28 (6): 1124-30 (Pubitemid 44883846)
43. Greenfield RO, Lee AC, Tang R, et al. Screening for asthma in Cantonesespeaking immigrant children. BMC Public Health 2005; 5: 48
44. Saglani S, McKenzie SA, Bush A, et al. A video questionnaire identifies upper airway abnormalities in preschool children with reported wheeze. Arch Dis Child 2005; 90 (9): 961-4 (Pubitemid 41232351)
45. Levin ME. Different use of medical terminology and culture-specific models of disease affecting communication between Xhosa-speaking patients and English-speaking doctors at a South African paediatric teaching hospital. S Afr Med J 2006; 96 (10): 1080-4 (Pubitemid 44649835)
46. Thompson L, Diaz J, Jenny A, et al. Nxwisen, ntzarrin or ntzo'lin? Mapping children's respiratory symptoms among indigenous populations in Guatemala. Soc Sci Med 2007; 65 (7): 1337-50 (Pubitemid 47314408)
47. Phankingthongkum S, Daengsuwan T, Visitsunthorn N, et al. How do Thai children and adolescents describe asthma symptoms? Pediatr Allergy Immunol 2002; 13 (2): 119-24 (Pubitemid 34525180)
48. Lai CK, Chan JK, Chan A, et al. Comparison of the ISAAC video questionnaire (AVQ3.0) with the ISAAC written questionnaire for estimating asthma associated with bronchial hyperreactivity. Clin Exp Allergy 1997; 27 (5): 540-5 (Pubitemid 27241652)
49. Levin ME. Use of asthma terminology by Xhosa-speaking patients in South Africa: how it affects asthma-control questionnaires and questionnaire-based epidemiological studies. Curr Allergy Clin Immunol 2007; 20 (2): 74-8
50. Enarson DA, Ait-Khaled N. Cultural barriers to asthma management. Pediatr Pulmonol 1999; 28 (4): 297-300 (Pubitemid 29468464)
51. Kleinman A, Eisenberg L, Good B. Culture illness and care: clinical lessons from anthropologic and cross-cultural research. Ann Intern Med 1978; 88: 251-8 (Pubitemid 8282164)
52. Pachter LM, Weller SC, Baer RD, et al. Variation in asthma beliefs and practices among mainland Puerto Ricans, Mexican-Americans, Mexicans, and Guatemalans. J Asthma 2002; 39 (2): 119-34
53. Deng Z. TCM diet therapy for bronchial asthma. J Tradit Chin Med 2009; 29 (3): 209-10
54. Laster N, Holsey CN, Shendell DG, et al. Barriers to asthma management among urban families: caregiver and child perspectives. J Asthma 2009; 46 (7): 731-9
55. Griffiths C, Kaur G, Gantley M, et al. Influences on hospital admission for asthma in south Asian and white adults: qualitative interview study. BMJ 2001; 323 (7319): 962-6 (Pubitemid 33016043)
56. Boyd M, Lasserson TJ, McKean MC, et al. Interventions for educating children who are at risk of asthma-related emergency department attendance. Cochrane Database Syst Rev 2009; (2): CD001290
57. Zemek RL, Bhogal SK, Ducharme FM. Systematic review of randomized controlled trials examining written action plans in children: what is the plan? Arch Pediatr Adolesc Med 2008; 162 (2): 157-63 (Pubitemid 351240723)
58. Espinoza-Palma T, Zamorano A, Arancibia F, et al. Effectiveness of asthma education with and without a self-management plan in hospitalized children. J Asthma 2009; 46 (9): 906-10
59. Bailey EJ, Cates CJ, Kruske SG, et al. Culture-specific programs for children and adults from minority groups who have asthma. Cochrane Database Syst Rev 2009; (2): CD006580
60. Chang AB, Shannon C, O'Neil MC, et al. Asthma management in indigenous children of a remote community using an indigenous health model. J Paediatr Child Health 2000; 36 (3): 249-51 (Pubitemid 30394923)
61. Ait-Khaled N, Enarson DA, Bissell K, et al. Access to inhaled corticosteroids is key to improving quality of care for asthma in developing countries. Allergy 2007; 62 (3): 230-6